- Posted on 02/28/2014
A new state-of-the-art treatment for brain tumors called Stereotactic Radiosurgery allows doctors to focus a set of X-ray beams on a single point inside the brain, killing cancer cells with a single large dose.
- Posted on 02/26/2014
Researchers have developed a unique, compact, relatively inexpensive imaging device to “light up” malignant brain tumors and other cancers.
- Posted on 02/24/2014
The St. Jude-Washington University Pediatric Cancer Genome Project has announced that it has identified the most common genetic alteration ever reported in the brain tumor ependymoma.
- Posted on 02/23/2014
Ependymoma is an aggressive type of brain cancer that primarily affects infants. A comprehensive molecular analysis of these tumors has now been carried out.
- Posted on 02/20/2014
...researchers have designed and tested a small device that can lure brain tumor cells into a killing trap without harming the healthy surrounding tissue.
- Posted on 02/19/2014
Scientists have developed a mathematical method for classifying forms of glioblastoma through variations in the way these tumor cells “read” genes.
- Posted on 02/18/2014
Researchers believe that they have found a way to treat inaccessible tumors by forcing them to move to their deaths using a "tumor monorail."
- Posted on 02/17/2014
The air pollution study is intended to determine whether ongoing exposure to air pollution causes molecular changes in the brain that are consistent with the development of brain tumor.
- Posted on 02/12/2014
- Posted on 02/11/2014
- Posted on 02/09/2014
- Posted on 02/04/2014
- Posted on 02/03/2014
- Posted on 01/28/2014
- Posted on 01/17/2014
- Posted by Ron Hirsch on 01/15/2014
Scientists have discovered how salt acts as a key regulator for drugs used to treat a variety of brain diseases including chronic pain, Parkinson's disease, and depression.
- Posted by Ron Hirsch on 01/12/2014
Metabolic dysregulation in tumors is a topic of intense interest in the study of cancer, and the therapeutic value of altering tumor metabolism is a new frontier in cancer research. Unlike genetic traits that may not be present in all cells of a patient’s tumor, one trait shared by virtually all tumor cells is altered metabolism.
- Posted by Ron Hirsch on 01/06/2014
Neurosurgeons at Houston Methodist Hospital removed a different lesion from Vincent’s brain through a tube inserted into a hole smaller than a dime and he went home the next day.
- Posted by Ron Hirsch on 01/04/2014
Bristol-Myers Squibb will start a Phase 2 study in patients with glioblastoma in which Bristol combines its experimental drug nivolumab with the approved Yervoy, and test it against different cancer types.
- Posted by Ron Hirsch on 12/24/2013
Working with mice, Johns Hopkins researchers have discovered that weeks of treatment with a repurposed FDA-approved drug halted the growth of — and ultimately left no detectable trace of — brain tumor cells taken from adult human patients.
- Posted by Ron Hirsch on 12/20/2013
New work may prompt a rethinking of targeted approaches to glioma treatment based on genetic profiling of tumors, and also argues for the judicious use of temozolomide (TMZ) used in glioma cases,
- Posted by Ron Hirsch on 12/18/2013
Scientists have discovered an enzyme in the "developmental pathway" of patients with embryonal tumors within multilayers rosettes which may lead to more effective treatment of the disease.
- Posted by Ron Hirsch on 12/15/2013
Team looked at human brain tumor samples and discovered that specialized immune cells in brain tumor patients are compromised. They identified a drug that is able to re-activate those immune cells and reduce brain tumor growth, thereby increasing the lifespan of mice two to three times.
- Posted by Ron Hirsch on 12/09/2013
In complex cases ranging from enlarged prostates to brain tumors, physicians are using virtual-reality simulators more and more to perfect their surgical techniques.
- Posted by Ron Hirsch on 12/08/2013
An experimental brain cancer treatment shows early signs that it can shrink tumors, according to trials conducted by San Diego-based Tocagen.
- Posted by Ron Hirsch on 12/06/2013
Cancer researchers say they have created a new and easier technique to diagnose brain tumors in just a half hour.
- Posted by Ron Hirsch on 12/02/2013
A team of researchers led by Dr. Jim Olson from the Seattle Children’s Hospital have developed an effective treatment for brain cancer using scorpion venom.
- Posted by Ron Hirsch on 11/25/2013
Eight of 16 patients participating in a study of an experimental immune system therapy directed against glioblastoma multiforme – survived longer than five years after diagnosis.
- Posted by Ron Hirsch on 11/23/2013
Imaging technique tells tumor tissue from normal tissue, could be used in operating room for real-time guidance of surgery
- Posted by Ron Hirsch on 11/19/2013
Agenus Inc., a developer of therapeutic vaccines for cancer and infectious diseases, today announced that its Prophage Series (HSPPC-96) vaccine program for the treatment of brain cancer was selected as a 2013 Top Project to Watch in oncology.
- Posted by Ron Hirsch on 11/10/2013
Glioblastoma multiform, the brain cancer that kills approximately 13,000 Americans a year, is aggressive and incurable. Now a Northwestern University research team is the first to demonstrate delivery of a drug that turns off a critical gene in this complex cancer, increasing survival rates significantly in animals with the deadly disease.
- Posted by Ron Hirsch on 11/06/2013
Precision is critical when it comes to operating on the brain. Brain tumors are located by using a 3D coordinate system along with an MRI.
- Posted by Ron Hirsch on 11/04/2013
Glioblastoma mutliforme (GBM) is one of the deadliest types of brain cancer. But now researchers from Northwestern University have demonstrated a way to potentially treat GBM by switching off a critical gene associated with the cancer.
- Posted by Ron Hirsch on 11/02/2013
A potential new drug, already in clinical development, can stop brain tumor cells growing while leaving healthy cells alone, according to new research published in PLOS ONE.
- Posted by Ron Hirsch on 10/30/2013
Having a tumor in the brain and having brain cancer aren't necessarily the same thing. More often than not, a brain tumor developed when cancer somewhere else, spread.
- Posted by Ron Hirsch on 10/26/2013
Receiving a cancer diagnosis is a scary moment, but for one patient, treatment at the Burzynski Clinic made a world of difference.
- Posted by Ron Hirsch on 10/25/2013
A new, cutting-edge procedure to remove brain tumors has been performed for the first time in the Natural State at the University of Arkansas for Medical Sciences (UAMS).
- Posted by Ron Hirsch on 10/23/2013
Scientists at Washington University School of Medicine in St. Louis have identified a biological marker that may help predict survival in people with deadly brain tumors.
- Posted by Ron Hirsch on 10/17/2013
Parvoviruses cause no harm in humans, but they can attack and kill cancer cells.
- Posted by Ron Hirsch on 10/15/2013
The struggle to conquer Cancer continues. Cancer is a deadly disease that strikes locally at first, then slowly usurps the processes of healthy normal cells, for its survival and progression, and eventually uproots the entire being.
- Posted by Ron Hirsch on 10/11/2013
The Israeli discovery of a cancer-driving protein could lead to a new weapon in the currently losing battle against brain tumors.
- Posted by Ron Hirsch on 10/04/2013
CLEVELAND, Ohio-- A drug used to treat blood disorders was successful at destroying human brain tumors implanted in mice in experiments performed at Johns Hopkins University.
- Posted by Ron Hirsch on 09/25/2013
Working with mice, Johns Hopkins researchers have discovered that weeks of treatment with a repurposed FDA-approved drug halted the growth of—and ultimately left no detectable trace of—brain tumor cells taken from adult human patients.
- Posted by Ron Hirsch on 09/24/2013
Scientists at the University of Alabama have identified a molecular pathway that seems to contribute to the ability of malignant glioma cells in a brain tumor to spread and invade previously healthy brain tissue.
- Posted by Ron Hirsch on 09/18/2013
Research supported by the Israel Cancer Research Fund (ICRF) is discovering previously unknown molecular aspects of brain cancer, providing new opportunities for diagnosis and treatment.
- Posted by Ron Hirsch on 09/14/2013
NIBIB-funded scientists and engineers are teaming up with neurosurgeons to develop technologies that enable less invasive, image-guided removal of hard-to-reach brain tumors.
- Posted by Ron Hirsch on 09/13/2013
Perhaps one of the most uncomfortable things a doctor has to tell patients is that their medical problems are iatrogenic. What that means is they were caused by a doctor in the course of the treatment.
Sometime these iatrogenic injuries are accidental. But sometimes, because of the limits of medical technology, they can be inevitable. Now, a medical researcher in Seattle thinks he has a way to eliminate some of the inevitable ones.
- Posted by Ron Hirsch on 09/12/2013
A team of University of Michigan Medical School and Harvard University researchers are turning to stimulated Raman scattering (SRS) to enable much more accurate brain tumor surgery. Combined with microscopy, the technique could allow surgeons to distinguish cancer tissue from normal brain tissue at the microscopic level while they are operating, and avoid leaving behind cells that could spawn a new tumor.
- Posted by Ron Hirsch on 09/05/2013
Brain tumors have always posed a challenge for neurosurgeons. They can reach tumors deep within the brain, but it's still difficult without damaging surrounding tissue. Now a new device called the Nico Brain Path provides minimally invasive surgery for patients who may have thought they were out of treatment options.
- Posted by Ron Hirsch on 09/04/2013
A new scanning technique developed by Danish and US researchers reveals how susceptible patients with aggressive brain cancer are to the drugs they receive. The research behind the ground-breaking technique has just been published in Nature Medicine
- Posted by Ron Hirsch on 08/24/2013
Watch this short news video about how the polio virus has been successfully used to kill brain tumor cells.
- Posted by Ron Hirsch on 08/24/2013
Voices Against Brain Cancer comments on a new MR analysis technique that reveals whether or not brain tumors are responding to angiogenesis therapy.
- Posted by Ron Hirsch on 08/17/2013
This year, 69,000 people will be told they have a brain tumor. People with the most aggressive forms are expected to live less than five years after receiving the diagnosis.
One major problem for surgeons is not being able to get the entire tumor removed. Now doctors are able to light up the tumor and see them better than ever before.
- Posted by Ron Hirsch on 08/15/2013
Surgeons may have a new way to smoke out cancer. An experimental surgical knife can help surgeons make sure they've removed all the cancerous tissue.
- Posted by Ron Hirsch on 08/09/2013
Neurosurgeons at the University of California, San Diego School of Medicine and UC San Diego Moores Cancer Center are among the first in the world to utilise real-time magnetic resonance imaging (MRI) guidance for delivery of gene therapy as a potential treatment for brain tumours.
- Posted by Ron Hirsch on 08/07/2013
The same virus that causes paralysis and sometimes death in polio patients may have the potential to cure people with cancerous brain tumors based on early results of a research trial underway at Duke University Medical Center.
- Posted by Ron Hirsch on 08/05/2013
A combination of two new therapies already in clinical trials for the treatment of primary malignant brain tumors may also be effective in the treatment of breast cancer that has spread to the brain, according to US researchers.
- Posted by Ron Hirsch on 08/05/2013
A team of researchers at the Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center has identified 18 new genes responsible for driving glioblastoma multiforme, the most common—and most aggressive—form of brain cancer in adults. The study was published August 5, 2013, in Nature Genetics.
- Posted on 08/02/2013
UCLA researchers successfully combine cellular and gene therapies
- Posted on 07/04/2013
University of Florida Health researchers have discovered a molecular pathway involved in the deadly spread of the most lethal kind of brain cancer (glioblastoma).
- Posted on 07/02/2013
Scientists have developed a new approach for treating a deadly brain cancer that strikes 15,000 in the United States annually and for which there is no effective long-term therapy. The researchers, from Yale and Johns Hopkins, have shown that the approach extends the lives of laboratory animals and are preparing to seek government approval for a human clinical trial.
UT Austin Participates In Moffitt Cancer Center Study That Shows Virus Combination Effective Against Deadly Brain TumorPosted on 06/30/2013
A collaborate effort between Peter A. Forsyth M.D.of Moffitts’ Neuro-Oncology Program, Tampa, Florida, University of Calgary, University of Texas, University of Florida and Ottawa Regional Cancer Centre Research Laboratories have found that a combination of the myxoma virus (an oncolytic virus) and the immune suppressant rapamycin (an antibiotic) has the ability to kill glioblastoma multiforme.
- Posted on 06/27/2013
Michael Graner, PhD, is a CU Cancer Center investigator and associate professor of neurosurgery at the CU School of Medicine. So when his 12-year-old Great Dane got sick, he knew what to do.
- Posted on 06/21/2013
Family size is a factor in the risk of developing a brain tumor, suggesting that infection may play a role. The factors affecting the risk of developing a brain tumor are not well understood. A team at the German Cancer Research Center reveals that childhood infection may play a role, through exposure to siblings.
- Posted on 03/01/2013
A medulloblastoma is a malignant brain tumor that occurs primarily in children and is currently untreatable. Peter Carmeliet and his team (VIB-KU Leuven) joined forces with scientists at Massachusetts General Hospital in Harvard to study the role of the placental growth factor (PIGF) in the growth of this brain tumor. They demonstrated that blocking PIGF inhibits the growth and metastasis of this cancer.
- Posted on 01/30/2013
This year it is expected that more than 195,000 people in the United States will be diagnosed with a brain tumor in some form. A mass of abnormal cells growing in the brain, a brain tumor can be malignant (cancerous) or benign (non-cancerous). With more than 120 different types of brain tumors, understanding the meaning of a diagnosis, the potential impact of the disease and options for treatment is often difficult and stressful for patients.
- Posted by Ron Hirsch on 12/06/2012
About 18,000 Americans each year are diagnosed with a brain cancer known as malignant glioma, but unfortunately, many do not survive. Researchers studying mice with these types of brain tumors have found that a specialized low-carbohydrate diet, known as the ketogenic diet, may enhance radiation treatment and could possibly extend survival.
Researchers Successfully Destroy Brain Tumor Cells; Use Unique Combination of Diet and Radiation TherapyPosted on 12/05/2012
A team of brain cancer researchers at Barrow Neurological Institute at St. Joseph's Hospital and Medical Center has effectively treated brain tumor cells using a unique combination of diet and radiation therapy.
- Posted on 12/04/2012
Sherry Finzer, who was Dill’s private flute instructor for about five years before the tumor was discovered, is planning her first winter flute recital that will collect donations for Dill.
- Posted on 11/16/2012
Insights from a genetic condition that causes brain cancer are helping scientists better understand the most common type of brain tumor in children.
- Posted on 11/04/2012
A Practical Tool for Navigating Survivorship.
Scott Norris - Brain Tumor Survivor (2011)
- Posted on 10/10/2012
UC Irvine doctors are enrolling patients with the deadly brain tumor glioblastoma multiforme in a clinical trial of a vaccine that may prevent the cancer's return or spread after surgery.